Literature DB >> 25814346

Percutaneous treatment of aorto-ostial coronary lesions: Current challenges and future directions.

Ronen Jaffe1, David A Halon2, Avinoam Shiran2, Ronen Rubinshtein2.   

Abstract

Flow-limiting aorto-ostial coronary lesions are clinically important because they subtend a large myocardial territory and may induce extensive myocardial ischemia. Diagnosis and treatment of these lesions is challenging and procedural success and clinical outcomes are inferior to non-ostial lesions. The purpose of this review is to summarize current knowledge regarding aorto-ostial percutaneous coronary intervention and to suggest novel approaches for optimizing these procedures.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aorto-ostial; Coronary artery disease; Geographic miss; Stent

Mesh：

Year:  2015        PMID： 25814346     DOI： 10.1016/j.ijcard.2015.03.161

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  4 in total

Review 1.  [Percutaneus coronary interventions for ostial lesions].

Authors:  J Wöhrle; S Markovic
Journal:  Herz       Date:  2016-11       Impact factor: 1.443

2.  Retrospective study of treatment with a drug-coated balloon alone is beneficial for ostial coronary lesions.

Authors:  Wenduo Zhang; Fusui Ji; Xue Yu; Chenguang Yang; Xinyue Wang
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 3.005

3.  Optimal Revascularization Strategy on Medina 0,1,0 Left Main Bifurcation Lesions in Type 2 Diabetes.

Authors:  Xuwei Zheng; Hongyu Peng; Donghui Zhao; Qin Ma; Kun Fu; Guo Chen; Qian Fan; Jinghua Liu
Journal:  J Diabetes Res       Date:  2016-09-29       Impact factor: 4.011

4.  Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions.

Authors:  Xiaoqiong Wang; Xuemei Zong; Bingqiang Li; Zhanying Han; Xinjie Duan; Ying Li; Jing Zhang; Yaohui Wang; Yaoli Wang
Journal:  BMC Cardiovasc Disord       Date:  2020-11-19       Impact factor: 2.298
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.